Parkinson's disease (PD) is a complex, progressive neurodegenerative disorder that primarily affects the motor system. It is characterized by the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies. This article provides a comprehensive overview of PD, from its etiology and pathophysiology to its diagnosis and management.
The exact cause of PD remains unknown, but it is believed to be a combination of genetic and environmental factors. Mutations in certain genes such as SNCA, LRRK2, and PRKN have been associated with familial PD. Pathologically, PD is characterized by the accumulation of alpha-synuclein protein in the form of Lewy bodies in the dopaminergic neurons, leading to neuronal death and dopamine depletion.
PD presents with both motor and non-motor symptoms. The cardinal motor symptoms include bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms can precede the motor symptoms and include olfactory dysfunction, sleep disorders, constipation, and mood disorders. The disease progression is typically slow and symptoms worsen over time.
PD diagnosis is primarily clinical, based on history and physical examination. Neuroimaging, such as DaTscan, can be used to support the diagnosis in uncertain cases. However, definitive diagnosis can only be confirmed by post-mortem examination.
There is currently no cure for PD. The primary goal of management is to control symptoms and improve quality of life. Pharmacological treatment includes levodopa, dopamine agonists, and MAO-B inhibitors. Non-pharmacological approaches include physiotherapy, occupational therapy, and in advanced cases, deep brain stimulation.
Understanding the complexities of Parkinson's disease is essential for healthcare providers to effectively diagnose and manage this condition. Ongoing research continues to provide new insights into the pathophysiology, potentially leading to novel therapeutic strategies in the future.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation